Niki Arrowsmith05.30.13
Instron, a Norwood, Mass.-based materials testing division of Illinois Tool Works Inc., has acquired Tissue Growth Technologies Corp. (TGT). TGT is a provider of tissue engineering bioreactors.
Terms of the deal were not disclosed.
With TGT in its armory, Instron now will be able to offer services including conditioning and engineering developing tissues, characterizing tissue engineering components, revealing fundamental mechanisms of cell function, directing stem cell differentiation, and providing an in vitro testbed for drug and cell therapy development.
“Instron and TGT are excited about this new partnership. Not only is Instron gaining the knowledge and experience of TGT, but we’re now able to provide a full range of solutions for the tissue engineering and regenerative medicine fields,” said James Ritchey, director of Instron tissue engineering businesses.
TGT has been developing its tissue engineering technology for 16 years. The company’s Dynagen series consists of modular and scalable instruments that provide the capability for repeatable and practical tissue growth. According to TGT, they can be configured with single and multiple samples driven from a common controller and laptop computer. TGT systems accommodate various scaffold materials, construct fabrication methods, stimulation mechanisms, and monitoring instruments to address a range of tissue engineering and regenerative medicine applications.
Terms of the deal were not disclosed.
With TGT in its armory, Instron now will be able to offer services including conditioning and engineering developing tissues, characterizing tissue engineering components, revealing fundamental mechanisms of cell function, directing stem cell differentiation, and providing an in vitro testbed for drug and cell therapy development.
“Instron and TGT are excited about this new partnership. Not only is Instron gaining the knowledge and experience of TGT, but we’re now able to provide a full range of solutions for the tissue engineering and regenerative medicine fields,” said James Ritchey, director of Instron tissue engineering businesses.
TGT has been developing its tissue engineering technology for 16 years. The company’s Dynagen series consists of modular and scalable instruments that provide the capability for repeatable and practical tissue growth. According to TGT, they can be configured with single and multiple samples driven from a common controller and laptop computer. TGT systems accommodate various scaffold materials, construct fabrication methods, stimulation mechanisms, and monitoring instruments to address a range of tissue engineering and regenerative medicine applications.